Pain management
Ended Awarded Last action
- Contract number
- SPE2D626F71V4
- Awardee
-
Boston Scientific Neuromodulation Corp UEI LQBMUJMLS256 Part of Boston Scientific Corp
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $43,792
Award facts
- Contract value 100% obligated
- $43,791.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Valencia, CA 91355, USA
Award details come from SAM.gov/FPDS.
About this award
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $43,791.77 on December 15, 2025, for pain management medical devices and services under a larger indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical branch. The delivery order, which is not designated as a set-aside, will be performed in Valencia, California, and is structured as a fixed-price contract with economic price adjustment provisions. This award falls under the SPE2DE indefinite delivery contract vehicle, valued at approximately $83.1 million and extending through August 16, 2026, which enables Boston Scientific Neuromodulation to provide comprehensive neuromodulation solutions to military and Veterans Affairs medical facilities nationwide.
The award supports the federal government's non-opioid pain management initiatives by delivering advanced spinal cord stimulation systems, implantable pain pumps, radiofrequency ablation devices, and associated accessories designed to help service members and veterans manage chronic pain from traumatic injuries. Boston Scientific Neuromodulation's product portfolio includes proprietary systems such as the RestoreSensor and Spectra WaveWriter spinal cord stimulators, along with technical support and training services. The contract, with an ultimate completion date of January 9, 2026, represents continued federal investment in specialized neuromodulation technologies as alternatives to opioid-based pain management solutions within the defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2D626F71V4?
SPE2D626F71V4 was awarded to Boston Scientific Neuromodulation Corp by Medical Supply Chain (Troop Support) on December 15, 2025.
How much is contract SPE2D626F71V4 worth?
The government has obligated $43,792 on SPE2D626F71V4.
Is contract SPE2D626F71V4 an order under another contract?
Yes. SPE2D626F71V4 is a delivery order under SPE2DE21D7009, an indefinite delivery contract.
Was contract SPE2D626F71V4 competed?
The extent of competition for SPE2D626F71V4 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award